Production of lycopene by metabolically-engineered Escherichia coli

Escherichia coli strain CAR001 that produces β-carotene was genetically engineered to produce lycopene by deleting genes encoding zeaxanthin glucosyltransferase (crtX) and lycopene β-cyclase (crtY) from the crtEXYIB operon. The resulting strain, LYC001, produced 10.5 mg lycopene/l (6.5 mg/g dry cell weight, DCW). Modulating expression of genes encoding α-ketoglutarate dehydrogenase, succinate dehydrogenase and transaldolase B within central metabolic modules increased NADPH and ATP supplies, leading to a 76 % increase of lycopene yield. Ribosome binding site libraries were further used to modulate expression of genes encoding 1-deoxy-d-xylulose-5-phosphate synthase (dxs) and isopentenyl diphosphate isomerase (idi) and the crt gene operon, which improved the lycopene yield by 32 %. The optimal strain LYC010 produced 3.52 g lycopene/l (50.6 mg/g DCW) in fed-batch fermentation.

[1]  S. Clinton,et al.  Lycopene: chemistry, biology, and implications for human health and disease. , 2009, Nutrition reviews.

[2]  B. Wanner,et al.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  L. Arab,et al.  Lycopene and cardiovascular disease. , 2000, The American journal of clinical nutrition.

[4]  W. R. Farmer,et al.  Precursor Balancing for Metabolic Engineering of Lycopene Production in Escherichia coli , 2001, Biotechnology progress.

[5]  G. Stephanopoulos,et al.  Tuning genetic control through promoter engineering. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Stephanopoulos,et al.  Identifying gene targets for the metabolic engineering of lycopene biosynthesis in Escherichia coli. , 2005, Metabolic engineering.

[7]  J. Keasling,et al.  Identification of genes affecting lycopene accumulation in Escherichia coli using a shot-gun method. , 2005, Biotechnology and bioengineering.

[8]  Gregory Stephanopoulos,et al.  Characterization of lycopene-overproducing E. coli strains in high cell density fermentations , 2006, Applied Microbiology and Biotechnology.

[9]  Jay D Keasling,et al.  Enhanced lycopene production in Escherichia coli engineered to synthesize isopentenyl diphosphate and dimethylallyl diphosphate from mevalonate , 2006, Biotechnology and bioengineering.

[10]  Jay D. Keasling,et al.  Engineering the lycopene synthetic pathway in E. coli by comparison of the carotenoid genes of Pantoea agglomerans and Pantoea ananatis , 2007, Applied Microbiology and Biotechnology.

[11]  G. Stephanopoulos,et al.  Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli. , 2007, Metabolic engineering.

[12]  Xueli Zhang,et al.  Production of l-alanine by metabolically engineered Escherichia coli , 2007, Applied Microbiology and Biotechnology.

[13]  H. Mukhtar,et al.  Cancer chemoprevention through dietary antioxidants: progress and promise. , 2008, Antioxidants & redox signaling.

[14]  O. Kucuk,et al.  Lycopene in Cancer Prevention and Treatment , 2008, American journal of therapeutics.

[15]  G. Stephanopoulos,et al.  Uncovering the gene knockout landscape for improved lycopene production in E. coli , 2008, Applied Microbiology and Biotechnology.

[16]  Xueli Zhang,et al.  Eliminating side products and increasing succinate yields in engineered strains of Escherichia coli C , 2008, Biotechnology and bioengineering.

[17]  A. Nagao.  Absorption and function of dietary carotenoids. , 2009, Forum of nutrition.

[18]  Jay D Keasling,et al.  Combinatorial expression of bacterial whole mevalonate pathway for the production of beta-carotene in E. coli. , 2009, Journal of biotechnology.

[19]  Sang Yup Lee,et al.  In Silico Identification of Gene Amplification Targets for Improvement of Lycopene Production , 2010, Applied and Environmental Microbiology.

[20]  K. Gibson,et al.  Detection of Bacterial Indicators and Human and Bovine Enteric Viruses in Surface Water and Groundwater Sources Potentially Impacted by Animal and Human Wastes in Lower Yakima Valley, Washington , 2010, Applied and Environmental Microbiology.

[21]  B. Guantario,et al.  Lycopene and cardiovascular diseases: an update. , 2011, Current medicinal chemistry.

[22]  Xueli Zhang,et al.  Combinatorial modulation of galP and glk gene expression for improved alternative glucose utilization , 2011, Applied Microbiology and Biotechnology.

[23]  Nam-Hee Kim,et al.  Increase of lycopene production by supplementing auxiliary carbon sources in metabolically engineered Escherichia coli , 2011, Applied Microbiology and Biotechnology.

[24]  Yanhe Ma,et al.  Activating transhydrogenase and NAD kinase in combination for improving isobutanol production. , 2013, Metabolic engineering.

[25]  Xueli Zhang,et al.  Engineering central metabolic modules of Escherichia coli for improving β-carotene production. , 2013, Metabolic engineering.

[26]  Jing Chen,et al.  Activating Phosphoenolpyruvate Carboxylase and Phosphoenolpyruvate Carboxykinase in Combination for Improvement of Succinate Production , 2013, Applied and Environmental Microbiology.

[27]  Activating C4-dicarboxylate transporters DcuB and DcuC for improving succinate production , 2014, Applied Microbiology and Biotechnology.